Janus Henderson Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.96M | Buy |
+523,743
| New | +$3.96M | ﹤0.01% | 979 |
|
|
2023
Q2 | – | Sell |
-8,452
| Closed | -$341K | – | 2618 |
|
|
2023
Q1 | $341K | Buy |
+8,452
| New | +$341K | ﹤0.01% | 2221 |
|
|
2022
Q2 | – | Sell |
-3,686
| Closed | -$262K | – | 2623 |
|
|
2022
Q1 | $262K | Buy |
3,686
+2
| +0.1% | +$142 | ﹤0.01% | 2301 |
|
|
2021
Q4 | $276K | Buy |
+3,684
| New | +$276K | ﹤0.01% | 2237 |
|
|
2020
Q1 | – | Sell |
-641,818
| Closed | -$39.7M | – | 1323 |
|
|
2019
Q4 | $39.7M | Sell |
641,818
-223,491
| -26% | -$13.8M | 0.02% | 663 |
|
|
2019
Q3 | $52M | Sell |
865,309
-79,478
| -8% | -$4.78M | 0.03% | 565 |
|
|
2019
Q2 | $79.7M | Buy |
944,787
+70,390
| +8% | +$5.94M | 0.04% | 447 |
|
|
2019
Q1 | $83.5M | Buy |
874,397
+126,804
| +17% | +$12.1M | 0.05% | 440 |
|
|
2018
Q4 | $53M | Buy |
747,593
+620,983
| +490% | +$44M | 0.03% | 522 |
|
|
2018
Q3 | $10.8M | Sell |
126,610
-9
| -0% | -$769 | 0.01% | 920 |
|
|
2018
Q2 | $14.7M | Sell |
126,619
-367,679
| -74% | -$42.6M | 0.01% | 864 |
|
|
2018
Q1 | $40M | Buy |
+494,298
| New | +$40M | 0.02% | 608 |
|